SCHEMBL3479706

SCHEMBL3479706

CN1CCN(c2ccccc2F)c2ccc(C(F)(F)F)cc2C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.45
FPR2 P25090 3/20 0.41
TP53 P04637 3/20 0.41
CYP3A4 P08684 3/20 0.41
ALDH1A1 P00352 3/20 0.41
MAPT P10636 3/20 0.41
LMNA P02545 3/20 0.41
HTR1A P08908 3/20 0.41
MAPK1 P28482 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41
TSHR P16473 2/20 0.41
NFKB1 P19838 2/20 0.41
HTR2C P28335 2/20 0.41
CYP2C19 P33261 2/20 0.41
THPO P40225 2/20 0.41
HTR3A P46098 2/20 0.41
HSD17B10 Q99714 2/20 0.41
HRH1 P35367 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479780 0.87 SCN9A (0.43) SCN9ATP53CYP3A4ALDH1A1LMNA
SCHEMBL3479532 0.86 SCN9A (0.45) SCN9AFPR2TP53CYP3A4ALDH1A1
SCHEMBL3222283 0.84 SCN9A (0.54) SCN9AFPR2TP53CYP3A4ALDH1A1
SCHEMBL3479531 0.84 SCN9A (0.48) SCN9AFPR2TP53CYP3A4ALDH1A1
SCHEMBL3224500 0.84 SLC6A2 (0.48) ALDH1A1MAPTHTR3ADRD2ADRA2C
SCHEMBL3222404 0.82 MEN1 (0.49) ALDH1A1MAPTLMNASMN1; SMN2DRD2
SCHEMBL3228455 0.81 ALDH1A1 (0.40) ALDH1A1DRD2HTR2ADRD1SLC6A2
SCHEMBL3479762 0.81 SCN9A (0.49) SCN9AALDH1A1LMNAHTR1ADRD2
SCHEMBL3479772 0.81 HTR3A (0.46) ALDH1A1MAPTLMNAMAPK1TSHR
SCHEMBL3479580 0.81 SCN9A (0.48) SCN9AFPR2TP53CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D SCN9A 795/4885FPR2 730/4885TP53 4868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.